Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
1.450
-0.040 (-2.68%)
At close: Apr 28, 2026, 4:00 PM EDT
1.300
-0.150 (-10.34%)
Pre-market: Apr 29, 2026, 8:14 AM EDT
Rein Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 41 | 30 | 50 | 15 | 11 | 51 | |
| Market Cap Growth | 8.13% | -38.81% | 234.56% | 38.39% | -78.89% | 20.50% | |
| Enterprise Value | 37 | 71 | 77 | 3 | -15 | -1 | |
| Last Close Price | 1.45 | 1.16 | 2.30 | 3.05 | 2.37 | 11.26 | |
| PB Ratio | 2.40 | 1.80 | 0.92 | 0.15 | 0.58 | 1.16 | |
| P/TBV Ratio | - | - | - | - | 0.58 | 1.16 | |
| Debt / Equity Ratio | - | - | - | 0 | 0.00 | 0.00 | |
| Net Debt / Equity Ratio | -0.19 | -0.19 | -0.24 | -0.18 | -1.14 | -1.04 | |
| Net Debt / EBITDA Ratio | 0.15 | 0.15 | 0.46 | 1.13 | 0.77 | 1.73 | |
| Net Debt / FCF Ratio | 0.17 | 0.17 | 0.58 | 0.87 | 0.85 | 1.91 | |
| Quick Ratio | 0.52 | 0.52 | 2.24 | 3.95 | 6.28 | 10.19 | |
| Current Ratio | 0.70 | 0.70 | 2.38 | 4.17 | 6.46 | 10.69 | |
| Return on Equity (ROE) | -139.87% | -139.87% | -82.37% | -26.91% | -87.41% | -93.33% | |
| Return on Assets (ROA) | -31.75% | -31.75% | -20.89% | -14.99% | -49.03% | -51.30% | |
| Return on Capital Employed (ROCE) | -122.00% | -122.00% | -49.80% | -15.10% | -148.50% | -60.50% | |
| Earnings Yield | -122.66% | -163.55% | -126.19% | -105.62% | -253.93% | -51.32% | |
| FCF Yield | -47.62% | -63.50% | -44.73% | -132.99% | -231.03% | -46.90% | |
| Buyback Yield / Dilution | -41.84% | -41.84% | -290.09% | -1.31% | -2.23% | -154.70% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.